Risk Factors for Linezolid Resistance in Staphylococcus Aureus

Completed

Conditions studied: Linezolid Resistance, Staphylococcus Aureus

In brief

This is a retrospective chart review study. The proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be assessed.

Key facts

Study ID

NCT00519025

Run by

University of Pittsburgh

People needed

360

Starts

2007-08-01

Expected to finish

2017-06-01

Last updated by the study team

2018-06-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients with linezolid resistance to staphylococcus aureus

You may not qualify if…

• those that don't meet entry criteria

Where it is running

• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.